Zhiai Xu

44PUBLICATIONS
46CO-AUTHORS
Molecular targetsMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Neural engineeringGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Oct 01, 2026
Protein Degradation Nanoparticles for Intraoperative Fluorescence Diagnosis and Postoperative Adjuvant Therapy of Solid Tumors.

|Jul 31, 2026
Engineering Polymeric Nano-PROTAC for Targeted Protein Degradation and Cancer Therapy.

|Jul 17, 2026
Molecular Engineering of Stimuli-Activatable Protein Degraders for Precise Cancer Therapy.

|Jun 18, 2026
POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancer.

|Jun 04, 2026
Glycoengineered Host-Guest Nanoparticles Potentiate Alzheimer's Disease Therapy via Lesion-Specific Modulation of Tau Pathology.

|Apr 03, 2026
Coassembled Prodrug Nanoparticles Mitigating the Acquired Resistance to Protein Degradation Therapy.

Jing Gao, Shumin Lei, Yiying Wang

Pageof 8

Frequent Collaborators

20 joint publications

Haijun Yu

14 joint publications

Wen Zhang

5 joint publications

Chunyong Ding

5 joint publications

Yang Tian